drugset / Trial / NCT01867606
Serum Bovine Immunoglobulin Protein Isolate in Improving Quality of Life and Post-Operative Recovery in Patients With Gynecological Cancer After Undergoing Surgery
RandomizedParallel-groupDouble-blindSupportive care
Summary
This randomized pilot phase II trial studies how well serum bovine immunoglobulin protein isolate works in improving quality of life and post-operative recovery in patients with cancer of the female reproductive tract after undergoing surgery. Serum bovine immunoglobulin may help provide nutrition to patients who are not able to eat or digest ordinary food. This may improve the quality of life of patients with gynecological cancer and help them recover more quickly from surgery.
Timeline
- Start
- 2013-10-04
- Primary completion
- 2015-11-21
- Completion
- 2015-11-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | serum-derived bovine immunoglobulin protein isolate | Protein / enzyme biologic | — | Oral |